Peeling off the genetics of atopic dermatitis–like congenital disorders - 02/10/14
Abstract |
The epidermis forms during the course of a complex differentiation process known as cornification, which culminates with the formation of the epidermal barrier. The epidermal barrier serves as a vital line of defense against the environment and mainly consists of 3 elements: intracellular keratin filaments, intercellular lipids, and the cornified cell envelope. Adequate epidermal barrier function is also critically dependent on normal shedding of terminally differentiated keratinocytes, a process termed desquamation, which requires the dissolution of cell-cell junctions in the upper granular layers. Although much has been learned about epidermal differentiation through the deciphering of the molecular basis of various cornification disorders, less is currently known about the mechanisms regulating epidermal desquamation and disorders resulting from disruption of this process. Netherton syndrome, peeling skin syndrome type B, and skin dermatitis—multiple severe allergies—metabolic wasting syndrome are 3 autosomal recessive conditions resulting from aberrant regulation of epidermal desquamation. The deciphering of their pathogenesis has not only broadened our understanding of this process but has also shed new light on clinical and mechanistic links between allergic reactions and abnormal desquamation, substantiating the notion that allergic manifestations might, under some circumstances, be the sole consequence of a primary epidermal defect.
Le texte complet de cet article est disponible en PDF.Key words : Netherton syndrome, peeling skin syndrome type-B, skin dermatitis, multiple severe allergies, and metabolic wasting syndrome, lymphoepithelial Kazal-type related inhibitor type 5, desmoglein 1, corneodesmosin
Abbreviations used : CDSN, DSC, DSG, FTT, KLK, LEKTI, LG, NS, PKP, PSS-B, SAM, SC, SG, SPINK5, TSLP
Plan
Supported by a generous donation of the Ram family (to E.S.). L.S. is recipient of an Excellence Award from the Tel Aviv Sourasky Medical Center. |
|
Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
Vol 134 - N° 4
P. 808-815 - octobre 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?